Glaxosmithkline traded at $43.69 this Friday June 24th, increasing $0.94 or 2.20 percent since the previous trading session. Looking back, over the last four weeks, Glaxosmithkline gained 2.85 percent. Over the last 12 months, its price rose by 9.83 percent. Looking ahead, we forecast Glaxosmithkline to be priced at 40.18 by the end of this quarter and at 37.10 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
43.69
Daily Change
2.20%
Yearly
9.83%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Takeda 3,707.00 2.00 0.05% -1.36%
AbbVie 152.34 2.89 1.93% 34.84%
Aurora Cannabis Inc 2.01 0.16 8.65% -82.13%
Amgen 245.37 2.28 0.94% 1.11%
AstraZeneca 10,776.00 396.00 3.82% 26.79%
Bristol-Myers Squibb 78.96 1.27 1.63% 18.31%
Corcept Therapeutics 23.80 0.55 2.37% 4.66%
Catalent 109.61 0 0% 0.41%
Endo International 0.37 -0.02 -5.72% -92.53%
Glaxosmithkline 43.69 0.94 2.20% 9.83%
Horizon Pharma 85.13 2.22 2.68% -11.25%
Jazz Pharmaceuticals 153.49 2.72 1.80% -15.24%
J&J 182.29 2.63 1.46% 11.01%
Lannett 0.58 -0.02 -3.35% -88.26%
Eli Lilly 325.62 12.90 4.13% 41.44%
Merck & Co 93.13 1.13 1.23% 20.63%
Novartis 80.60 2.37 3.03% -4.80%
Phibro Animal Health 20.30 1.34 7.07% -28.65%
Prestige Brands 58.90 2.23 3.94% 11.47%
Pacira 57.43 1.15 2.04% -9.59%
Pfizer 51.59 1.50 2.99% 32.35%
Powershares High Yield Orate Bond Portfolio 17.10 0.10 0.59% -12.31%
Perrigo 41.21 0.90 2.23% -12.09%
Drreddys Laboratories 55.92 0.92 1.67% -22.21%
Roche Holding 318.80 12.50 4.08% -7.54%
Sanofi 100.56 4.81 5.02% 13.95%
Supernus Pharmaceuticals 28.40 0.01 0.04% -13.04%
Teva Pharmaceutical Industries Ltd 2,677.00 18.00 0.68% -20.07%
United States Oil Fund 81.27 2.29 2.90% 61.73%
Bausch Health Companies Inc 11.28 1.83 19.37% -69.33%
Canopy Growth Corp 4.88 0.20 4.27% -83.93%
Zoetis 174.61 5.44 3.22% -6.74%


Glaxosmithkline
GlaxoSmithKline PLC is a global healthcare company. The Company operates through two segments: Pharmaceuticals and Vaccines. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency virus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. The Company makes a range of prescription medicines and vaccines products. The Pharmaceuticals business discovers, develops and commercializes medicines to treat a range of acute and chronic diseases. The Vaccines business provides vaccines for people of all ages from babies and adolescents to adults and older people. It has a portfolio of medicines in respiratory and HIV. Its Pharmaceuticals business includes Respiratory, HIV, Specialty products, and Classic and Established products. Its Vaccines business has a portfolio of over 40 pediatric, adolescent, adult, older people and travel vaccines.